Mosaic ImmunoEngineering (CPMV) Stock Overview
A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CPMV Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Mosaic ImmunoEngineering, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.39 |
| 52 Week High | US$1.05 |
| 52 Week Low | US$0.25 |
| Beta | -0.83 |
| 1 Month Change | -35.00% |
| 3 Month Change | -3.70% |
| 1 Year Change | -44.35% |
| 3 Year Change | -60.61% |
| 5 Year Change | -88.00% |
| Change since IPO | -92.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| CPMV | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -21.7% | 1.7% | 1.3% |
| 1Y | -44.3% | 27.1% | 15.8% |
Return vs Industry: CPMV underperformed the US Biotechs industry which returned 27.1% over the past year.
Return vs Market: CPMV underperformed the US Market which returned 15.8% over the past year.
Price Volatility
| CPMV volatility | |
|---|---|
| CPMV Average Weekly Movement | 93.8% |
| Biotechs Industry Average Movement | 11.3% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CPMV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CPMV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 5 | Steven King | www.mosaicie.com |
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Mosaic ImmunoEngineering, Inc. Fundamentals Summary
| CPMV fundamental statistics | |
|---|---|
| Market cap | US$2.82m |
| Earnings (TTM) | -US$671.75k |
| Revenue (TTM) | n/a |
Is CPMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CPMV income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$671.75k |
| Earnings | -US$671.75k |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.093 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -22.5% |
How did CPMV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/26 17:46 |
| End of Day Share Price | 2025/12/22 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mosaic ImmunoEngineering, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.